Matches in Nanopublications for { ?s ?p "[Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 21 of
21
with 100 items per page.
- NP229770.RAQ7sQvgnya_rmHzPdSUXXZ8UhYVvdeltVvZHsKfAaRLc130_assertion description "[Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP229770.RAQ7sQvgnya_rmHzPdSUXXZ8UhYVvdeltVvZHsKfAaRLc130_provenance.
- NP298874.RAj2-2mgECDOfFi-L2JuAM0z34NgqdvkjkuNMEW_-_-mQ130_assertion description "[Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP298874.RAj2-2mgECDOfFi-L2JuAM0z34NgqdvkjkuNMEW_-_-mQ130_provenance.
- NP338305.RAsXr1Gm21NQtXysu1cPloM6vh1RaCz1MkLP1b7jbWUlI130_assertion description "[Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338305.RAsXr1Gm21NQtXysu1cPloM6vh1RaCz1MkLP1b7jbWUlI130_provenance.
- NP659370.RAXIrbOENxrCDVk0GbICC8PTse1ufgo2Vsq91nA0-UjgQ130_assertion description "[Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP659370.RAXIrbOENxrCDVk0GbICC8PTse1ufgo2Vsq91nA0-UjgQ130_provenance.
- NP662390.RAXzDxYLeusTowlvN0cSQxupEajvxsB1EIbExkRTMRtgk130_assertion description "[Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP662390.RAXzDxYLeusTowlvN0cSQxupEajvxsB1EIbExkRTMRtgk130_provenance.
- assertion description "[Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP668798.RAc45JrSa2HTlHu38JmgJp1stkOq3epvL6QUx-97Tl8_M130_assertion description "[Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668798.RAc45JrSa2HTlHu38JmgJp1stkOq3epvL6QUx-97Tl8_M130_provenance.
- NP668800.RAWPW2mbVfSmi3OlrExKltwR58MbSDq55Rvymq2qf5fzo130_assertion description "[Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668800.RAWPW2mbVfSmi3OlrExKltwR58MbSDq55Rvymq2qf5fzo130_provenance.
- NP668802.RAdaFm3H9D_FSaQ5yqBD5c8W-9Fsqb64TasuU73id-0M0130_assertion description "[Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668802.RAdaFm3H9D_FSaQ5yqBD5c8W-9Fsqb64TasuU73id-0M0130_provenance.
- NP668805.RAWRC443jilpw5V5au8uyNY31RHP4BqwFPGb33G5QdY4w130_assertion description "[Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668805.RAWRC443jilpw5V5au8uyNY31RHP4BqwFPGb33G5QdY4w130_provenance.
- NP977575.RAibB7C_XYr4MjG1fVIx8JzUOEfNFh9k56rVJvApl1nJY130_assertion description "[Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977575.RAibB7C_XYr4MjG1fVIx8JzUOEfNFh9k56rVJvApl1nJY130_provenance.
- NP977580.RAoGhHn2nDc7HsERVoRdSUQpeMxNpkYXNyjWLnDFkwjgI130_assertion description "[Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977580.RAoGhHn2nDc7HsERVoRdSUQpeMxNpkYXNyjWLnDFkwjgI130_provenance.
- NP668803.RAhGouqslWcCpk4lYxpxi2AI9e_w27yrSR15aqPyshTXI130_assertion description "[Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668803.RAhGouqslWcCpk4lYxpxi2AI9e_w27yrSR15aqPyshTXI130_provenance.
- NP662398.RAIXZ1pffenW4u9iZ15Ia0XKQx8F4gBWqzJsvwd5peU0o130_assertion description "[Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP662398.RAIXZ1pffenW4u9iZ15Ia0XKQx8F4gBWqzJsvwd5peU0o130_provenance.
- NP659357.RA0P4sykPMUbDDv_f3NftP2eUh2X67sdNZs2YD8MsNJ24130_assertion description "[Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP659357.RA0P4sykPMUbDDv_f3NftP2eUh2X67sdNZs2YD8MsNJ24130_provenance.
- NP668804.RA6G4HVHBcqGFixDZnZMgGVgqPvsvfD9_vXyEtpw5yk6I130_assertion description "[Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668804.RA6G4HVHBcqGFixDZnZMgGVgqPvsvfD9_vXyEtpw5yk6I130_provenance.